Prostaglandin D2, a potential antineoplastic agent
Data up to Jan 2025
Total Citations Per Year
Abstract
References (11)
Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species
1978 • 339 citations
Prostaglandins and cancer: A review of tumor initiation through tumor metastasis
1981 • 273 citations
Prostaglandin D2 inhibits the aggregation of human platelets
1974 • 230 citations
15-Hydroxyprostaglandin dehydrogenase. A review
1976 • 209 citations
Human B cell, T cell and null cell leukaemic cell lines derived from acute lymphoblastic leukaemias
1977 • 180 citations
Prostaglandin D2 as a potential antithrombotic agent
1975 • 111 citations
Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cells
1979 • 105 citations
Inhibition of DNA synthesis in harding-passey melanoma cells by prostaglandins A1 and A2: Comparison with chemotherapeutic agents
1979 • 53 citations
Prostaglandin A1 inhibition of chondrosarcoma growth
1974 • 36 citations
High Terminal Deoxynucleotidyl Transferase Activity in a New T-Cell Line (RPMI 8402) of Acute Lymphoblastic Leukemia Origin 2
1975 • 22 citations
Nucleosome-histone acetyltransferase from rat liver chromatin
1980 • 18 citations
Cited By (0)
No citing papers found in database